Altamira Therapeutics .(CYTO) - 2022 Q2 - Quarterly Report
Altamira Therapeutics .(CYTO)2022-11-29 16:00Exhibit 99.1 Unaudited Condensed Consolidated Interim Financial Statements as of June 30, 2022 and December 31, 2021 and for the Six Months Ended June 30, 2022 and 2021 | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------|-------| | | | | Condensed Consolidated Interim Statement of Profit or Loss and Other Comprehensive Income or Loss | 2 | | Condensed Consolidated Interim Statement of Financial Position | 3 | | Condense ...